Diabetes drugs

Search documents
Novo Nordisk to buy Akero Therapeutics for up to $5.2 billion
Yahoo Financeยท 2025-10-09 10:31
STOCKHOLM (Reuters) -Novo Nordisk said on Thursday it had agreed to buy Akero Therapeutics for up to $5.2 billion, giving the Danish drugmaker access to the U.S.-based company's experimental liver disease drug. The maker of blockbuster obesity drug Wegovy is pressing ahead with a sweeping restructuring in a bid to revive sales growth and fend off intense competition from U.S. rival Eli Lilly. Under the deal, Novo would pay Akero shareholders $54 per share upfront in cash, which represents a premium of ab ...